Literature DB >> 1716614

Lymphokine secretion and cytotoxic activity of human CD4+ T-cell clones against Bordetella pertussis.

S Peppoloni1, L Nencioni, A Di Tommaso, A Tagliabue, P Parronchi, S Romagnani, R Rappuoli, M T De Magistris.   

Abstract

Human CD4+ T-cell clones specific for pertussis toxin and other Bordetella pertussis antigens have been tested for their cytotoxic activity, lymphokine production, and capacity to induce immunoglobulin synthesis. Clones specific for the S1 subunit of pertussis toxin were cytotoxic for autologous Epstein-Barr virus-transformed B cells, which had been pulsed with the native antigen, the recombinant S1 subunit of pertussis toxin, or synthetic peptides derived from the S1 amino acid sequence. The killing of antigen-pulsed target cells was class II restricted. All of the T-cell clones produced mostly interleukin-2 and gamma interferon and assisted allogeneic B cells in the production of immunoglobulins M and G but not immunoglobulin E. The potential in vivo role of the cytotoxic activity of these clones is discussed.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1716614      PMCID: PMC258949          DOI: 10.1128/iai.59.10.3768-3773.1991

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  35 in total

1.  Induction of I region-restricted hapten-specific cytotoxic T lymphocytes.

Authors:  H Wagner; A Starzinski-Powitz; H Jung; M Röllinghoff
Journal:  J Immunol       Date:  1977-10       Impact factor: 5.422

2.  Characterization of genetically inactivated pertussis toxin mutants: candidates for a new vaccine against whooping cough.

Authors:  L Nencioni; M Pizza; M Bugnoli; T De Magistris; A Di Tommaso; F Giovannoni; R Manetti; I Marsili; G Matteucci; D Nucci
Journal:  Infect Immun       Date:  1990-05       Impact factor: 3.441

3.  Profiles of lymphokine activities and helper function for IgE in human T cell clones.

Authors:  E Maggi; G Del Prete; D Macchia; P Parronchi; A Tiri; I Chrétien; M Ricci; S Romagnani
Journal:  Eur J Immunol       Date:  1988-07       Impact factor: 5.532

4.  Biological characterization of mouse 'early' antibodies.

Authors:  I Mota
Journal:  Immunology       Date:  1967-03       Impact factor: 7.397

5.  Acquisition of specific cytotoxic activity by human T4+ T lymphocytes in culture.

Authors:  B Fleischer
Journal:  Nature       Date:  1984 Mar 22-28       Impact factor: 49.962

6.  Recognition of hepatitis B virus envelope proteins by liver-infiltrating T lymphocytes in chronic HBV infection.

Authors:  V Barnaba; A Franco; A Alberti; C Balsano; R Benvenuto; F Balsano
Journal:  J Immunol       Date:  1989-10-15       Impact factor: 5.422

7.  A T cell activity that enhances polyclonal IgE production and its inhibition by interferon-gamma.

Authors:  R L Coffman; J Carty
Journal:  J Immunol       Date:  1986-02-01       Impact factor: 5.422

8.  Human monoclonal antibodies to a genus-specific chlamydial antigen, produced by EBV-transformed B cells.

Authors:  A Rosén; K Persson; G Klein
Journal:  J Immunol       Date:  1983-06       Impact factor: 5.422

9.  IgE production by normal human lymphocytes is induced by interleukin 4 and suppressed by interferons gamma and alpha and prostaglandin E2.

Authors:  J Pène; F Rousset; F Brière; I Chrétien; J Y Bonnefoy; H Spits; T Yokota; N Arai; K Arai; J Banchereau
Journal:  Proc Natl Acad Sci U S A       Date:  1988-09       Impact factor: 11.205

10.  Metabolic, humoral, and cellular responses in adult volunteers immunized with the genetically inactivated pertussis toxin mutant PT-9K/129G.

Authors:  A Podda; L Nencioni; M T De Magistris; A Di Tommaso; P Bossù; S Nuti; P Pileri; S Peppoloni; M Bugnoli; P Ruggiero
Journal:  J Exp Med       Date:  1990-09-01       Impact factor: 14.307

View more
  20 in total

1.  Distinct T-cell subtypes induced with whole cell and acellular pertussis vaccines in children.

Authors:  M Ryan; G Murphy; E Ryan; L Nilsson; F Shackley; L Gothefors; K Oymar; E Miller; J Storsaeter; K H Mills
Journal:  Immunology       Date:  1998-01       Impact factor: 7.397

2.  Bordetella pertussis proteins dominating the major histocompatibility complex class II-presented epitope repertoire in human monocyte-derived dendritic cells.

Authors:  Rachel M Stenger; Hugo D Meiring; Betsy Kuipers; Martien Poelen; Jacqueline A M van Gaans-van den Brink; Claire J P Boog; Ad P J M de Jong; Cécile A C M van Els
Journal:  Clin Vaccine Immunol       Date:  2014-03-05

3.  Pertussis-specific cell-mediated immunity in infants after vaccination with a tricomponent acellular pertussis vaccine.

Authors:  F Zepp; M Knuf; P Habermehl; J H Schmitt; C Rebsch; P Schmidtke; R Clemens; M Slaoui
Journal:  Infect Immun       Date:  1996-10       Impact factor: 3.441

4.  Th1/Th2 cell dichotomy in acquired immunity to Bordetella pertussis: variables in the in vivo priming and in vitro cytokine detection techniques affect the classification of T-cell subsets as Th1, Th2 or Th0.

Authors:  A Barnard; B P Mahon; J Watkins; K Redhead; K H Mills
Journal:  Immunology       Date:  1996-03       Impact factor: 7.397

5.  Cell-invasive activity of epitope-tagged adenylate cyclase of Bordetella pertussis allows in vitro presentation of a foreign epitope to CD8+ cytotoxic T cells.

Authors:  P Sebo; C Fayolle; O d'Andria; D Ladant; C Leclerc; A Ullmann
Journal:  Infect Immun       Date:  1995-10       Impact factor: 3.441

6.  Humoral and cellular immune responses in mice immunized with recombinant Mycobacterium bovis Bacillus Calmette-Guérin producing a pertussis toxin-tetanus toxin hybrid protein.

Authors:  B Abomoelak; K Huygen; L Kremer; M Turneer; C Locht
Journal:  Infect Immun       Date:  1999-10       Impact factor: 3.441

7.  Vaccine- and antigen-dependent type 1 and type 2 cytokine induction after primary vaccination of infants with whole-cell or acellular pertussis vaccines.

Authors:  C M Ausiello; F Urbani; A la Sala; R Lande; A Cassone
Journal:  Infect Immun       Date:  1997-06       Impact factor: 3.441

8.  Pertussis toxin-induced alterations of murine hepatic drug metabolism following administration of diphtheria and tetanus toxoids and pertussis vaccine adsorbed.

Authors:  S Ansher; W Thompson; J Bridgewater; P Snoy
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

9.  Bordetella pertussis infection of primary human monocytes alters HLA-DR expression.

Authors:  Jennifer A Shumilla; Vashti Lacaille; Tara M C Hornell; Jennifer Huang; Supraja Narasimhan; David A Relman; Elizabeth D Mellins
Journal:  Infect Immun       Date:  2004-03       Impact factor: 3.441

10.  Effective immunization against Bordetella pertussis respiratory infection in mice is dependent on induction of cell-mediated immunity.

Authors:  K Redhead; J Watkins; A Barnard; K H Mills
Journal:  Infect Immun       Date:  1993-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.